George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 26,724 shares at $39.76 ($1.1M) on 2021-07-26, disclosed to the SEC on 2021-07-27.
Open-market sale of $1.1M RPRX by EVP, Investments & GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.76 | 8,449 | $336K | 31.6% |
| 2 | $39.76 | 8,449 | $336K | 31.6% |
| 3 | $39.81 | 4,913 | $196K | 18.4% |
| 4 | $39.81 | 4,913 | $196K | 18.4% |
| Total | $39.78 avg | 26,724 | $1.1M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |